Hepatic chemosaturation with melphalan in patients with primary or secondary liver tumors with or without extrahepatic tumor manifestation

Hepatic chemosaturation with melphalan in patients with primary or secondary liver tumors with or without extrahepatic tumor manifestation

Background: Hepatic chemosaturation by isolated percutaneous liver perfusion (CS-PHP) with melphalan controls hepatic tumor growth. However, optimal treatment frequency and the prognostic relevance of extrahepatic tumor manifestation remain unclear. We analyzed response and tolerability of repeated...

Full description

Bibliographic Details
Main Authors: R. Veelken, S. Ebel, A. Schindler, F. Lordick, M.F. Struck, C. Girbardt, F. Ziemssen, D. Seehofer, T. Denecke, T. Berg, F. van Bömmel
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:ESMO Gastrointestinal Oncology
Subjects:
liver tumor
uveal melanoma
chemosaturation
melphalan
experimental treatment
tebentafusp
Online Access:http://www.sciencedirect.com/science/article/pii/S2949819824000438

Internet

http://www.sciencedirect.com/science/article/pii/S2949819824000438

Similar Items